While there’s been limited action in Congress on marijuana legislation so far this year, that hasn’t stopped a variety of interests—including advocacy organizations, industry stakeholders, prohibitionists, beer distributors, pharmaceutical companies and more—from putting dollars toward federal lobbying on the issue. A look at the latest lobbying disclosures for the 2nd quarter of 2025, which covers…...
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
